Archer Pharmaceuticals

Archer Pharmaceuticals, Inc. (Archer) was founded in 2008 and specializes in targeted drug discovery for Alzheimers disease. Led by Chief Executive Officer and Chief Scientific Officer Michael Mullan, M.B.B.S., Ph.D. and Chief Technical Officer and Associate Chief Scientific Officer Fiona Crawford, Ph.D., Archer was created based on the groundbreak... ing research conducted at the Roskamp Institute in Sarasota, Florida. Included in this research is clinical development of Nilvadipine as a therapeutic for Alzheimers Disease. A Phase I/IIA human clinical trial was conducted in Alzheimers patients in partnership with the Trinity College Institute of Neuroscience in Dublin, Ireland. This trial showed that Nilvadipine was well-tolerated in Alzheimers disease patients, and, together with extensive preclinical data in laboratory models of Alzheimers Disease, laid the foundation for a Phase III double-blind, placebo-controlled clinical trial of Nilvadipine (NILVAD) which is currently ongoing in Europe.Read More